Literature DB >> 22790978

Postoperative autologous blood transfusion drain or no drain in primary total hip arthroplasty? A randomised controlled trial.

Wieger G Horstmann1, Bart M Kuipers, Rob Slappendel, Rene M Castelein, Boudewijn J Kollen, Cees C P M Verheyen.   

Abstract

PURPOSE: Postoperative maintenance of high haemoglobin (Hb) levels and avoidance of homologous blood transfusions is important in total hip arthroplasty (THA). The introduction of a postoperative drainage autologous blood transfusion (ABT) system or no drainage following THA has resulted in reduction of homologous blood transfusion requirements compared with closed-suction drains. The purpose of this study was to examine which regimen is superior following THA.
METHODS: A randomised controlled blinded prospective single-centre study was conducted in which 100 THA patients were randomly allocated to ABT or no drainage. The primary endpoint was the Hb level on the first postoperative day.
RESULTS: The postoperative collected drained blood loss was 274 (±154) ml in the ABT group, of which 129 (±119) ml was retransfused (0-400). There was no statistical difference in Hb levels on the first postoperative day (ABT vs no drainage: Hb 11.0 vs 10.9 g/dl), on consecutive days (day 3: Hb 10.7 vs 10.2, p = 0.08) or in total blood loss (1,506 vs 1,633 ml), homologous transfusions, pain scores, Harris Hip Score, SF-36 scores, length of hospital stay or adverse events.
CONCLUSIONS: The use of a postoperative autologous blood retransfusion drain did not result in significantly higher postoperative Hb levels or in less total blood loss or fewer homologous blood transfusions compared with no drain.

Entities:  

Mesh:

Year:  2012        PMID: 22790978      PMCID: PMC3460103          DOI: 10.1007/s00264-012-1613-7

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  25 in total

1.  Clinical efficacy of postoperative autologous transfusion of filtered shed blood in hip and knee arthroplasty.

Authors:  D Strümper; E W G Weber; S Gielen-Wijffels; R Van Drumpt; S Bulstra; R Slappendel; M E Durieux; M A E Marcus
Journal:  Transfusion       Date:  2004-11       Impact factor: 3.157

2.  Intraoperative autotransfusion in primary hip arthroplasty. A randomized comparison with homologous blood.

Authors:  A A Elawad; A K Ohlin; E Berntorp; I M Nilsson; H Fredin
Journal:  Acta Orthop Scand       Date:  1991-12

Review 3.  Redefining ischemia due to circulatory failure as dual defects of oxygen deficits and of carbon dioxide excesses.

Authors:  B A Johnson; M H Weil
Journal:  Crit Care Med       Date:  1991-11       Impact factor: 7.598

4.  Postoperative anemia does not impede functional outcome and quality of life early after hip and knee arthroplasties.

Authors:  Elise Vuille-Lessard; Daniel Boudreault; François Girard; Monique Ruel; Miguel Chagnon; Jean-François Hardy
Journal:  Transfusion       Date:  2011-08-02       Impact factor: 3.157

5.  Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation.

Authors:  W H Harris
Journal:  J Bone Joint Surg Am       Date:  1969-06       Impact factor: 5.284

6.  Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study.

Authors:  J E Ware; M Kosinski; M S Bayliss; C A McHorney; W H Rogers; A Raczek
Journal:  Med Care       Date:  1995-04       Impact factor: 2.983

7.  Estimating allowable blood loss: corrected for dilution.

Authors:  J B Gross
Journal:  Anesthesiology       Date:  1983-03       Impact factor: 7.892

8.  Erythrocyte viability in blood salvaged during total joint arthroplasty with cement.

Authors:  Clifford W Colwell; Ernest Beutler; Carol West; Mary E Hardwick; Beverly A Morris
Journal:  J Bone Joint Surg Am       Date:  2002-01       Impact factor: 5.284

9.  Infection or suspected infection after hip replacement surgery with autologous or homologous blood transfusions.

Authors:  P Murphy; J M Heal; N Blumberg
Journal:  Transfusion       Date:  1991 Mar-Apr       Impact factor: 3.157

10.  Hidden blood loss following hip and knee arthroplasty. Correct management of blood loss should take hidden loss into account.

Authors:  K R Sehat; R L Evans; J H Newman
Journal:  J Bone Joint Surg Br       Date:  2004-05
View more
  8 in total

1.  Favourable results of a new intraoperative and postoperative filtered autologous blood re-transfusion system in total hip arthroplasty: a randomised controlled trial.

Authors:  Wieger G Horstmann; Martzen J Swierstra; David Ohanis; Rob Rolink; Boudewijn J Kollen; Cees C P M Verheyen
Journal:  Int Orthop       Date:  2014-01       Impact factor: 3.075

2.  Simultaneous bilateral total hip arthroplasties do not lead to higher complication or allogeneic transfusion rates compared to unilateral procedures.

Authors:  Sergio Romagnoli; Sara Zacchetti; Paolo Perazzo; Francesco Verde; Giuseppe Banfi; Marco Viganò
Journal:  Int Orthop       Date:  2013-07-24       Impact factor: 3.075

Review 3.  Cell Salvage at the ICU.

Authors:  Stephan L Schmidbauer; Timo F Seyfried
Journal:  J Clin Med       Date:  2022-07-02       Impact factor: 4.964

4.  Blood loss reduction in cementless total hip replacement with fibrin spray or bipolar sealer: a randomised controlled trial on ninety five patients.

Authors:  Francesco Falez; Antonio Meo; Gabriele Panegrossi; Fabio Favetti; Filippo La Cava; Filippo Casella
Journal:  Int Orthop       Date:  2013-05-18       Impact factor: 3.075

5.  Blood management and transfusion strategies in 600 patients undergoing total joint arthroplasty: an analysis of pre-operative autologous blood donation.

Authors:  Paolo Perazzo; Marco Viganò; Laura De Girolamo; Francesco Verde; Anna Vinci; Giuseppe Banfi; Sergio Romagnoli
Journal:  Blood Transfus       Date:  2013-05-07       Impact factor: 3.443

6.  De-implementation of expensive blood saving measures in hip and knee arthroplasties: study protocol for the LISBOA-II cluster randomized trial.

Authors:  Veronique M A Voorn; Perla J Marang-van de Mheen; Cynthia So-Osman; Ad A Kaptein; Anja van der Hout; M Elske van den Akker-van Marle; Ankie W M M Koopman-van Gemert; Albert Dahan; Rob G H H Nelissen; Thea P M M Vliet Vlieland; Leti van Bodegom-Vos
Journal:  Implement Sci       Date:  2014-04-23       Impact factor: 7.327

7.  Analysis of the Need for Postoperative Drainage Application for Hip Arthroplasty: A Systematic Review and Meta-Analysis.

Authors:  Min Yang; Chunwen Yan; Nasha Niu; Yingzi Lu; Wei Yue; Li Pan
Journal:  Comput Math Methods Med       Date:  2022-02-24       Impact factor: 2.238

8.  Application of postoperative autotransfusion in total joint arthroplasty reduces allogeneic blood requirements: a meta-analysis of randomized controlled trials.

Authors:  Weiping Ji; Xianfeng Lin; Ruoxia Zhang; Pan Tang; Jian Mo; Xinyi Teng; Qiuping Fan; Bo Wang; Shunwu Fan; Jianfeng Zhang; Shuai Chen; Kangmao Huang
Journal:  BMC Musculoskelet Disord       Date:  2017-09-02       Impact factor: 2.362

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.